These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12819868)

  • 1. The effect of FTY 720 on engraftment in a model of spontaneous allograft acceptance.
    Koshiba T; Van Damme B; Ji P; Sefrioui H; Rutgeerts O; Waer M; Pirenne J
    Transpl Int; 2003 Jun; 16(6):383-90. PubMed ID: 12819868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory cell-mediated tolerance does not protect against chronic rejection.
    Koshiba T; Kitade H; Van Damme B; Giulietti A; Overbergh L; Mathieu C; Waer M; Pirenne J
    Transplantation; 2003 Aug; 76(3):588-96. PubMed ID: 12923449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
    Koshiba T; Van Damme B; Rutgeerts O; Waer M; Pirenne J
    Transplantation; 2003 Apr; 75(7):945-52. PubMed ID: 12698078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal ischemia reperfusion and lipopolysaccharide transform a tolerogenic signal into a sensitizing signal and trigger rejection.
    Kawai M; Kitade H; Koshiba T; Waer M; Pirenne J
    Transplantation; 2009 May; 87(10):1464-7. PubMed ID: 19461482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Break of tolerance via donor-specific blood transfusion by high doses of steroids: a differential effect after intestinal transplantation and heart transplantation.
    Koshiba T; Kitade H; Waer M; Mathieu C; Van Damme B; Pirenne J
    Transplant Proc; 2003 Dec; 35(8):3153-5. PubMed ID: 14698001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
    J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T; Kiyochi H; Honda K; Kobayashi N
    Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical early upregulation of intragraft Th1 cytokines is associated with graft acceptance following donor-specific blood transfusion.
    Koshiba T; Giulietti A; Van Damme B; Overbergh L; Rutgeerts O; Kitade H; Waer M; Mathieu C; Pirenne J
    Transpl Int; 2003 Mar; 16(3):179-85. PubMed ID: 12664213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
    J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival.
    Wasowska B; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):175-80. PubMed ID: 1370737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early accumulation of interferon-gamma in grafts tolerized by donor-specific blood transfusion: friend or enemy?
    Kitade H; Kawai M; Koshiba T; Giulietti A; Overbergh L; Rutgeerts O; Valckx D; Waer M; Mathieu C; Pirenne J
    Transplantation; 2004 Dec; 78(12):1747-55. PubMed ID: 15614147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver allografts are toleragenic in rats conditioned with posttransplant total lymphoid irradiation.
    Nagasaki K; Obara H; Xiong A; Kambham N; Strober S; Esquivel CO; Millan MT
    Transplantation; 2007 Sep; 84(5):619-28. PubMed ID: 17876275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of donor-specific blood transfusion enhancement of rat renal allografts with accelerated development of antiidiotypic antibodies and reduced alloantibody responses.
    Downey WE; Baldwin WM; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):160-6. PubMed ID: 2301006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
    Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW
    Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
    J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permanent acceptance of both cardiac and skin allografts using a mild conditioning regimen for the induction of stable mixed chimerism in mice.
    van Pel M; Hilbrands L; Smits D; van Breugel DW; van Eck M; Boog CJ
    Transpl Immunol; 2003; 11(1):57-63. PubMed ID: 12727476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.